These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 8914662)

  • 1. Abstracts of the 9th Meeting of the European Association of NeuroOncology. September 16-19, 2010. Maastricht, The Netherlands.
    Neuro Oncol; 2010 Sep; 12 Suppl 3(Suppl 3):iii1-66. PubMed ID: 20729246
    [No Abstract]   [Full Text] [Related]  

  • 2. Fourteenth Meeting of the European Neurological Society, 26-30 June 2004, Barcelona, Spain. Abstracts.
    J Neurol; 2004 Jun; 251 Suppl 3():III1-III206. PubMed ID: 15221311
    [No Abstract]   [Full Text] [Related]  

  • 3. Abstracts of the 13th Meeting of the European Neurological Society. 14-18 June 2003, Istanbul, Turkey.
    J Neurol; 2003 May; 250 Suppl 2():II1-224. PubMed ID: 12868443
    [No Abstract]   [Full Text] [Related]  

  • 4. Abstracts of the 12th Meeting of the European Neurological Society. 22-26 June 2002, Berlin, Germany.
    J Neurol; 2002 Jun; 249 Suppl 1():I1-224. PubMed ID: 12186000
    [No Abstract]   [Full Text] [Related]  

  • 5. 5th Meeting of the European Neurological Society. Munich, Germany, 17-21 June 1995. Abstracts.
    J Neurol; 1995 Jun; 242(6 Suppl 2):S1-161. PubMed ID: 7650544
    [No Abstract]   [Full Text] [Related]  

  • 6. Abstracts of the Twentieth Meeting of the European Neurological Society. June 19-23, 2010. Berlin, Germany.
    J Neurol; 2010 Jun; 257 Suppl 1():S3-231. PubMed ID: 20495927
    [No Abstract]   [Full Text] [Related]  

  • 7. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group.
    Johnson KP; Brooks BR; Cohen JA; Ford CC; Goldstein J; Lisak RP; Myers LW; Panitch HS; Rose JW; Schiffer RB
    Neurology; 1995 Jul; 45(7):1268-76. PubMed ID: 7617181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis: trial of a synthetic polypeptide.
    Bornstein MB; Miller AI; Teitelbaum D; Arnon R; Sela M
    Ann Neurol; 1982 Mar; 11(3):317-9. PubMed ID: 7092185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis.
    Bornstein MB; Miller A; Slagle S; Weitzman M; Crystal H; Drexler E; Keilson M; Merriam A; Wassertheil-Smoller S; Spada V
    N Engl J Med; 1987 Aug; 317(7):408-14. PubMed ID: 3302705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled, double-blind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis.
    Bornstein MB; Miller A; Slagle S; Weitzman M; Drexler E; Keilson M; Spada V; Weiss W; Appel S; Rolak L
    Neurology; 1991 Apr; 41(4):533-9. PubMed ID: 2011253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6th Meeting of the European Neurological Society. The Hague, The Netherlands, 8-12 June 1996. Abstracts.
    J Neurol; 1996 Jun; 243(6 Suppl 2):S1-140. PubMed ID: 8914662
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE PRESENT STATUS OF RADIOTHERAPY OF NEUROLOGICAL DISEASES].
    ZDANSKY E
    Schweiz Med Wochenschr; 1963 Sep; 93():1316-9. PubMed ID: 14050474
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.